News

BIOTRONIK announced the first patients enrolled in the BioInsight clinical study. The study evaluates the safety and feasibility of performing the minimally invasive BioMonitor 2 insertion procedure in an office setting. BioMonitor 2 is an...

The American Heart Association (AHA) Scientific Sessions 2016 took place on November 12-16 in New Orleans, Louisiana. Included is a compilation of clinical news highlights from the meeting.

New Phase 3b results from the PIONEER AF-PCI study met its primary endpoint and showed that both XARELTO® (rivaroxaban) groups had significantly reduced risk of bleeding compared to the warfarin arm in people with non-valvular atrial...

Medtronic plc has received U.S. Food and Drug Administration (FDA) approval for the Claria MRI(TM) Quad Cardiac Resynchronization Therapy Defibrillator (CRT-D) SureScan(TM) device for patients with heart failure. The Claria MRI CRT-D is...

Boehringer Ingelheim Pharmaceuticals, Inc., Anthem, Inc. and HealthCore Inc. announced the final results from the first phase of a three phase, large-scale research collaboration to generate real-world evidence to help inform the development...

Boston Scientific announced initial U.S. commercial performance results of the WATCHMAN™ Left Atrial Appendage Closure (LAAC) Device during a late-breaking clinical trial session at the 28th Transcatheter Cardiovascular Therapeutics (TCT),...

St. Jude Medical, Inc., a global medical device company, presented favorable results from the largest observational study to date of the company’s AMPLATZER™ Amulet™ left atrial appendage (LAA) occluder. The data were presented in a Late...

AliveCor, the leader in FDA-cleared mobile electrocardiogram (ECG/EKG) technology for mobile devices, announced it is integrating weight and activity reading across iOS and Android platforms, enabling consumers to now capture five of the most...

Using specialized CT scans of a healthy heart and one with heart disease, a team of Johns Hopkins cardiologists and biomedical engineers say they've created computer models of the "shape" of blood flow through the heart's upper left chamber...

St. Jude Medical, Inc., a global medical device company, announced the U.S. Food and Drug Administration (FDA) approval and launch of the AMPLATZER™ PFO Occluder to help reduce the risk of recurrent ischemic strokes in patients diagnosed with...